3Spittler A, Razenberger M, Kupper H, et al. Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties,and cytokine production[J]. Clin Infect Dis ,2000,31(6): 1338～ 1420.
4American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis,assessment of severity , and initial antimicrobial therapy. Am Rew Respir Dis, 1993, 148(5): 1418～1426.
5Connelius HG, Nommann SI. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumors asites. J Immunol,1998,141:2175.
6Lin K J, Lin J, Hanasawa K. Interleukin-8 as a predictor of the severity of bacteremia and infectious disease[J].Shock, 2000,14 (2): 95 - 100.
7Mira JP,Cariou A, Grall F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicoated study. JAMA,1999,282(6): 561-568.
9Schroder JM.Mrowietz T.Morita E.et al.Purification and paritital biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin-1 activity.J Immunol.1987.139:43474.
